DUSA Insider Trading Activity and SEC Form 4 Filings
DUSA insider trading summary
No open-market insider purchases or sales of Dusa Pharmaceuticals Inc (DUSA) have been reported on SEC Form 4 in the past 12 months.
Latest DUSA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 16, 2012 | Scott L Lundahl | VP, Regulatory Affairs & IP | Sell | $11K (1,900 @ $5.76) |
| Mar 16, 2012 | Scott L Lundahl | VP, Regulatory Affairs & IP | Sell | $46K (7,976 @ $5.75) |
| Mar 16, 2012 | Scott L Lundahl | VP, Regulatory Affairs & IP | Sell | $5K (800 @ $5.81) |
| Mar 16, 2012 | Scott L Lundahl | VP, Regulatory Affairs & IP | Sell | $9K (1,600 @ $5.84) |
| Mar 16, 2012 | Scott L Lundahl | VP, Regulatory Affairs & IP | Sell | $30K (5,224 @ $5.80) |
| Mar 12, 2012 | Stuart L Marcus | VP, Sc. Aff & CMO | Sell | $6K (1,048 @ $5.85) |
| Mar 12, 2012 | Stuart L Marcus | VP, Sc. Aff & CMO | Sell | $870 (148 @ $5.88) |
| Mar 12, 2012 | Stuart L Marcus | VP, Sc. Aff & CMO | Sell | $587 (100 @ $5.87) |
| Mar 12, 2012 | Stuart L Marcus | VP, Sc. Aff & CMO | Sell | $304 (52 @ $5.84) |
| Mar 12, 2012 | Stuart L Marcus | VP, Sc. Aff & CMO | Sell | $7K (1,149 @ $5.91) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.